Skip to content
Screener

Roivant Sciences ROIV United Kingdom — Net operating losses

Similar metrics at other companies

Belden logo
BDCUnited Kingdom — Net Operating Loss Carryforwards
$17.32M-2.6%
Insmed logo
INSMUnited Kingdom — Operating loss carryforwards
$95.7M+95.7%
Ingredion logo
INGRUnited Kingdom — Net operating loss carryforwards, foreign
$1M0.0%
Belden logo
BDCUnited  States — Net Operating Loss Carryforwards
$35.83M-8.7%
Hayward Holdings logo
HAYWUnited States — Net operating loss carryforward
$12.6M0.0%
SSR Mining logo
SSRMUnited States — Tax operating losses
$1.39M+0.1%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:17 AM EDT
Fiscal year
FY2025
Accession
0001635088-26-000061

The Company has net operating losses in Switzerland, the U.S. and the U.K. in the amount of $1,512.9 million, $890.7 million and $613.4 million, respectively. The Switzerland net operating losses will expire in varying amounts between March 31, 2027 and March 31, 2032. The U.S. net operating losses can be carried forward indefinitely with utilization limited to 80% of future taxable income for tax years beginning on or after January 1, 2021, while the U.K. and other net operating losses can be carried forward indefinitely as well, with an annual limitation on utilization. The Company has $66.0 million of federal research tax credit carryforwards in the U.S., which will expire in varying amounts between March 31, 2039 and March 31, 2046. Additionally, credits of $10.8 million are related to various states and Canada.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Roivant Sciences's united kingdom — net operating losses?
Roivant Sciences (ROIV) reported united kingdom — net operating losses of $613.4M in Q1 2026.
How has Roivant Sciences's united kingdom — net operating losses changed year-over-year?
Roivant Sciences's united kingdom — net operating losses increased by 79.4% year-over-year, from $342M to $613.4M.
What does united kingdom — net operating losses mean?
This metric represents the cumulative tax losses generated by the company's operations within the United Kingdom that are available to offset future taxable income. It serves as a key indicator of the tax efficiency and historical investment intensity of the UK-based research and development activities. Investors monitor this figure to assess the potential for future tax shields and the overall fiscal impact of the company's regional operational structure.

Ask your AI about Roivant Sciences's united kingdom — net operating losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude